Why BGPT?
logo

Check Claims Before You Publish

See how your reported results read as versioned evidence records — linked to experiments and limitations.Know what the science actually supports before you trust the answer.

Press Enter ↵ to review claims



    Explore by Goal












     Quick Explanation


    Yonah Langcauon — Scientific strength (evidence-limited)
    Based on the provided record (1 work; ~1 citation; h-index ~1), the evidence base for judging long-term research impact is extremely small. The main review signal here is therefore probative content quality of the single paper and methodological transparency, which are not included in your input.



     Long Explanation


    Author Review: Yonah Langcauon
    Science-focused, skeptical, evidence-weighted critique—limited by missing paper metadata (methods, results, DOI, data, and full text).
    1) What we can verify from your provided record
    • Works: 1
    • Citation count: 0 (prompt metadata) vs cited-by count: 1 (OpenAlex snippet in your prompt)
    • h-index: 0 (prompt metadata) vs h-index: 1 (OpenAlex snippet in your prompt)
    • ORCID: included in your prompt metadata (0009-0009-0488-4660)
    • Top work (by your list): “Role of microbiota in the outcome of immune checkpoint inhibition therapy of cancer”
    Critical note: The prompt contains internally conflicting metrics (0 vs 1 for citations/h-index). When author-impact metrics disagree across sources, the safest stance is that the true impact signal is too uncertain to drive a high-confidence evaluation.
    2) Visual evidence: raw bibliometric snapshot (from your prompt)
    3) Scientific strength evaluation (what’s inferable vs not)
    Known from your input
    • The author has one listed publication in your provided record.
    • The listed work’s topic is microbiota and outcomes of immune checkpoint inhibition (ICI) in cancer.
    Not provided (major missing evidence)
    • Paper DOI, journal/conference, year
    • Study design (review/meta-analysis? observational? mechanistic? animal model? RCT?)
    • Effect sizes, endpoints, uncertainty estimates
    • Data availability, protocols, reproducibility checks
    • Whether claims are grounded in primary experiments vs synthesis of heterogeneous literature
    • Author contribution and whether coauthors provide key methodological rigor
    Consequences for rigor (skeptical reasoning)
    • With only one listed work, it’s not possible to assess track record: replication attempts, methodological evolution, correction of errors, and learning curves are unobservable.
    • Bibliometric impact (citations/h-index) is a weak proxy for biological insight, especially with tiny sample sizes. It can be dominated by networking, venue visibility, or citation lag.
    • The topic area (microbiota–ICI outcomes) is known to be high-variance due to confounding (diet, antibiotics, baseline tumor/host immunity, geography, sequencing pipelines). Without the paper’s controls and analysis strategy, causal strength cannot be judged from title alone.
    • If the work is a narrative review, it may be vulnerable to selection bias and overgeneralization across studies with incompatible methods (16S vs shotgun, batch effects, different outcome definitions).
    Bottom-line evidence posture
    From the information you provided, I can only give a low-confidence scientific quality assessment: the topic is scientifically plausible, but there is insufficient evidence to evaluate experimental rigor, data-groundedness, and reproducibility.
    4) How to audit the author’s actual scientific strength (action checklist)
    A. If it’s a review/meta-analysis
    • Check whether it follows a PRISMA-like process and whether inclusion/exclusion criteria are pre-specified.
    • Check how heterogeneity is handled (random effects, stratification, sensitivity analyses).
    • Check risk-of-bias assessment and whether study quality is weighted.
    • Check whether the review distinguishes associations from mechanisms (and how it labels uncertainty).
    B. If it’s primary research
    • Check sample sizes and power (and whether multiple-testing corrections are used).
    • Check covariate handling for microbiome confounding (antibiotics, diet proxy variables, baseline performance status).
    • Check whether results persist across technical replicates and independent cohorts.
    • Check whether functional claims are supported (metagenomics vs taxa-only correlations).
    • Check data availability and whether code exists for re-analysis.
    5) Information I would need to upgrade this review from low- to high-confidence
    • DOI (so I can cite precisely and verify paper details)
    • Year, journal, and whether it’s primary research vs synthesis
    • Abstract + methods + results (or full text)
    • Any reported quantitative outputs (effect sizes, CIs, p-values adjusted, AUC/calibration)
    • Whether the paper provides microbiome analysis pipeline details (and raw/processed data availability)
    6) Scores (critical, evidence-limited)
    • Scientific quality: low-to-moderate (1/10) because there is not enough content evidence in your input to evaluate rigor.
    • Scientific rigor: very low confidence (2/10) for the same reason; rigor can’t be assessed without methods/results.
    • Communication: unassessable from your input (set conservatively).
    • Novelty: unassessable from your input; title alone is not enough to infer novelty.


    Feedback:    

    Updated: April 08, 2026

     BGPT Author Review


    Scientific Quality

    10%

    Only 1 publication is provided, and no DOI/methods/results/full text are included. Therefore, the scientific quality cannot be evaluated beyond topic plausibility. The bibliometric signals are internally conflicting and extremely small-sample, so impact-based inference is unreliable. Overall evidence is insufficient to assign meaningful rigor/insight; score is therefore very low due to missing core evaluation data.


    Communication Quality

    30%

    No manuscript text, abstract, figures, or reasoning structure is provided. With no observable writing artifacts, communication quality cannot be assessed; the score is set conservatively above minimum to reflect that publication existence does not imply poor communication, but there is no evidence either way.


    Author Novelty

    30%

    The title suggests a topic within an established research area (microbiota ↔ ICI outcomes), but novelty cannot be determined without knowing what specific contributions were made (new data, new mechanism, new cohort, new synthesis method). With only the title, novelty assessment is highly uncertain.


    Scientific Rigor

    20%

    Rigor depends on study design, controls, statistical methods, reproducibility, and uncertainty quantification, none of which are provided. With missing methods/results, rigor can’t be verified; the score reflects that evaluation is not possible rather than confirmed low rigor.

     Analysis Wizard



    It will extract key study variables from the provided paper text and compute robustness summaries (effect sizes, heterogeneity, and sensitivity) directly from the described methods and reported results.



     Hypothesis Graveyard


    “A single microbial genus universally predicts ICI response.” — Unlikely because microbiome studies are typically cohort/pipeline dependent and strongly confounded without harmonization and covariate control.


    “Correlations in patient microbiome are sufficient to claim mechanism.” — Overreaches; without causal experiments or validated pathway-level evidence, association does not establish mechanism.

     Science Art


    Author Review: Yonah Langcauon Science Art

     Science Movie


    Make a narrated HD Science movie for this answer ($32 per minute)




     Discussion


    Stay current without chasing every paper.

    Know what changed, what holds up, and what remains uncertain. Every Friday. No ads.


    My BGPT






     Trending